Timing looks right for Biomet IPO

Back to TopCommentsE-mailPrintBookmark and Share

The owners of Warsaw-based Biomet Inc. may have gotten the timing right this time.

The group of private equity funds that acquired Biomet in June 2007 last week filed to take the company back onto the public markets, selling $100 million in stock later this year.

The company is owned by Blackstone Group, Goldman Sachs, KKR & Co. and TPG Capital.

Their timing the first time was poor. Three months after the group paid a whopping $11.4 billion for Biomet, orthopedic implant makers settled with the U.S. Department of Justice, agreeing to alter their cozy consulting relationships with surgeons, which dampened sales. Then three months later, the national recession hit, causing a sharp deceleration in growth rates of knee and hip replacements.

This time, Biomet’s owners are hitting the orthopedics market on the upswing, according to Bernstein Research analyst Lisa Clive. In a March 7 report to investors, Clive noted that domestic consumer sentiment continues to strengthen, which suggests more Americans will continue to go back to get the hip and knee replacements they put off during the prolonged economic downturn.

That trend emerged in the second half of 2013 and now looks like it will continue throughout this year.

“In the U.S., the demand-driven nature of the health care system means that we should see a continuation of the orthopedic market recovery that began in the second half of 2013, as consumer sentiment trends continue to stabilize close to pre-recession levels,” Clive wrote. She predicts U.S. knee implant sales will grow 5 percent and hip sales 6 percent this year, excluding currency fluctuations.

Biomet’s sales of knee implants have grown faster than the industry the past two years, according to Clive. Biomet sales of hip implants equaled the industry’s in 2013 and exceeded it the year before.

Despite global recession headwinds, Biomet has increased its profitability since 2007, financial reports to its public bondholders show.

Biomet has seen earnings before interest, taxes, depreciation and amortization rise, when adjusted for extraordinary items, from $719 million in 2007 to nearly $1.1 billion last year, according to a Deutsche Bank Securities Inc. analysis.

Cash flow from operations was $440 million in 2007, but now stands at $523 million.

Part of those improvements came through sales growth, from $2.1 billion in 2007 to nearly $3.1 billion last year. Sales to markets outside the United States and Europe more than doubled, from $205 million to more than $480 million. Biomet also acquired the trauma implant business from crosstown rival DePuy Orthopaedics Inc., which helped boost overall sales.

And part of the improvement has come from cutting more than $170 million in annual expenses. By June 30, Biomet will have closed seven of the 18 factories it operated in 2007, according to Deutsche Bank.

Still, Deutsche Bank analyst Kristen Stewart estimates the value of Biomet’s entire business at $11 billion to $13 billion—not far from the price the owners paid seven years ago.

That’s largely because growth prospects for orthopedic implant makers, in spite of recent improvements, are still not where they were in 2007.

“A lot has changed since Biomet was taken private, and the overall growth for the worldwide hip/knee market outlook has slowed from the high-single-digit growth rate experienced in 2007 to the low- to mid-single-digit growth expected in 2014,” wrote Glenn Novarro, an analyst at RBC Capital Markets.


Post a comment to this story

We reserve the right to remove any post that we feel is obscene, profane, vulgar, racist, sexually explicit, abusive, or hateful.
You are legally responsible for what you post and your anonymity is not guaranteed.
Posts that insult, defame, threaten, harass or abuse other readers or people mentioned in IBJ editorial content are also subject to removal. Please respect the privacy of individuals and refrain from posting personal information.
No solicitations, spamming or advertisements are allowed. Readers may post links to other informational websites that are relevant to the topic at hand, but please do not link to objectionable material.
We may remove messages that are unrelated to the topic, encourage illegal activity, use all capital letters or are unreadable.

Messages that are flagged by readers as objectionable will be reviewed and may or may not be removed. Please do not flag a post simply because you disagree with it.

Sponsored by

facebook - twitter on Facebook & Twitter

Follow on TwitterFollow IBJ on Facebook:
Follow on TwitterFollow IBJ's Tweets on these topics:
Subscribe to IBJ
  1. If I were a developer I would be looking at the Fountain Square and Fletcher Place neighborhoods instead of Broad Ripple. I would avoid the dysfunctional BRVA with all of their headaches. It's like deciding between a Blackberry or an iPhone 5s smartphone. BR is greatly in need of updates. It has become stale and outdated. Whereas Fountain Square, Fletcher Place and Mass Ave have become the "new" Broad Ripples. Every time I see people on the strip in BR on the weekend I want to ask them, "How is it you are not familiar with Fountain Square or Mass Ave? You have choices and you choose BR?" Long vacant storefronts like the old Scholar's Inn Bake House and ZA, both on prominent corners, hurt the village's image. Many business on the strip could use updated facades. Cigarette butt covered sidewalks and graffiti covered walls don't help either. The whole strip just looks like it needs to be power washed. I know there is more to the BRV than the 700-1100 blocks of Broad Ripple Ave, but that is what people see when they think of BR. It will always be a nice place live, but is quickly becoming a not-so-nice place to visit.

  2. I sure hope so and would gladly join a law suit against them. They flat out rob people and their little punk scam artist telephone losers actually enjoy it. I would love to run into one of them some day!!

  3. Biggest scam ever!! Took 307 out of my bank ac count. Never received a single call! They prey on new small business and flat out rob them! Do not sign up with these thieves. I filed a complaint with the ftc. I suggest doing the same ic they robbed you too.

  4. Woohoo! We're #200!!! Absolutely disgusting. Bring on the congestion. Indianapolis NEEDS it.

  5. So Westfield invested about $30M in developing Grand Park and attendance to date is good enough that local hotel can't meet the demand. Carmel invested $180M in the Palladium - which generates zero hotel demand for its casino acts. Which Mayor made the better decision?